Skip to main content

Advertisement

Log in

Vascular endothelial growth factor levels in patients with obstructive sleep apnea: a meta-analysis

  • Review Article
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Published articles regarding the blood levels of vascular endothelial growth factor (VEGF) in obstructive sleep apnea (OSA) patients are contradictory. The objective of this study was to explore whether VEGF levels is high or not in OSA subjects via quantitatively statistical analysis. The electronic databases of Pubmed, Web of Science, EMBASE were systematic searched. The VEGF levels and clinical characteristics of participants between OSA group and control group were extracted for analysis. Weighted mean difference (WMD) or standard mean difference (SMD) with 95 % confidence interval (CI) was calculated by fixed effects or random effects model. Appropriate statistical software was employed for data synthesis. Totaling 15 articles with 697 participants were included in this study. Pooled meta-analysis showed that blood VEGF concentrations were significantly higher in OSA patients than in control subjects (SMD 1.89, 95 % CI 0.92–2.87, p = 0.000). Subgroup analysis demonstrated that when compared with control group, OSA patients with age ≥50 years (SMD 2.54, 95 % CI 1.28–3.80, p = 0.000), apnea hypopnea index ≥30 events/h (SMD 2.47, 95 % CI 1.20–3.73, p = 0.000) had higher VEGF levels. Compared with control subjects, OSA patients had an elevated VEGF in serum (SMD 3.55, 95 % CI 1.82–5.28, p = 0.000) rather than in plasma. High blood VEGF concentrations were observed in OSA patients, particularly in the older and more serious patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328(17):1230–1235. doi:10.1056/NEJM199304293281704

    Article  CAS  PubMed  Google Scholar 

  2. Udwadia ZF, Doshi AV, Lonkar SG, Singh CI (2004) Prevalence of sleep-disordered breathing and sleep apnea in middle-aged urban Indian men. Am J Respir Crit Care Med 169(2):168–173. doi:10.1164/rccm.200302-265OC

    Article  PubMed  Google Scholar 

  3. Patil SP, Schneider H, Schwartz AR, Smith PL (2007) Adult obstructive sleep apnea: pathophysiology and diagnosis. Chest 132(1):325–337. doi:10.1378/chest.07-0040

    Article  PubMed  PubMed Central  Google Scholar 

  4. Drager LF, Polotsky VY, Lorenzi-Filho G (2011) Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest 140(2):534–542. doi:10.1378/chest.10-2223

    Article  PubMed  PubMed Central  Google Scholar 

  5. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto FJ, O’Connor GT, Boland LL, Schwartz JE, Samet JM (2001) Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163(1):19–25. doi:10.1164/ajrccm.163.1.2001008

    Article  CAS  PubMed  Google Scholar 

  6. Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365(9464):1046–1053. doi:10.1016/S0140-6736(05)71141-7

    Article  PubMed  Google Scholar 

  7. Nieto FJ, Peppard PE, Young T, Finn L, Hla KM, Farre R (2012) Sleep-disordered breathing and cancer mortality: results from the Wisconsin Sleep Cohort Study. Am J Respir Crit Care Med 186(2):190–194. doi:10.1164/rccm.201201-0130OC

    Article  PubMed  PubMed Central  Google Scholar 

  8. Marshall NS, Wong KK, Cullen SR, Knuiman MW, Grunstein RR (2014) Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the Busselton Health Study cohort. J Clin Sleep Med 10(4):355–362. doi:10.5664/jcsm.3600

    PubMed  PubMed Central  Google Scholar 

  9. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246(4935):1306–1309

    Article  CAS  PubMed  Google Scholar 

  10. Lin TH, Su HM, Wang CL, Voon WC, Shin SJ, Lai WT, Sheu SH (2010) Vascular endothelial growth factor polymorphisms and extent of coronary atherosclerosis in Chinese population with advanced coronary artery disease. Am J Hypertens 23(9):960–966. doi:10.1038/ajh.2010.104

    Article  CAS  PubMed  Google Scholar 

  11. Inoue M, Itoh H, Ueda M, Naruko T, Kojima A, Komatsu R, Doi K, Ogawa Y, Tamura N, Takaya K, Igaki T, Yamashita J, Chun TH, Masatsugu K, Becker AE, Nakao K (1998) Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 98(20):2108–2116

    Article  CAS  PubMed  Google Scholar 

  12. Salven P, Manpaa H, Orpana A, Alitalo K, Joensuu H (1997) Serum vascular endothelial growth factor is often elevated in disseminated cancer. Clin Cancer Res 3(5):647–651

    CAS  PubMed  Google Scholar 

  13. Devery AM, Wadekar R, Bokobza SM, Weber AM, Jiang Y, Ryan AJ (2015) Vascular endothelial growth factor directly stimulates tumour cell proliferation in non-small cell lung cancer. Int J Oncol 47(3):849–856. doi:10.3892/ijo.2015.3082

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359(6398):843–845. doi:10.1038/359843a0

    Article  CAS  PubMed  Google Scholar 

  15. Philippe C, Boussadia Y, Pruliere-Escabasse V, Papon JF, Clerici C, Isabey D, Coste A, Escudier E, d’Ortho MP (2015) Airway cell involvement in intermittent hypoxia-induced airway inflammation. Sleep Breath 19(1):297–306. doi:10.1007/s11325-014-1019-4

    Article  CAS  PubMed  Google Scholar 

  16. Tekin D, Dursun AD, Bastug M, Karaorman G, Ficicilar H (2011) The effects of acute and intermittent hypoxia on the expressions of HIF-1alpha and VEGF in the left and right ventricles of the rabbit heart. Anadolu Kardiyol Derg 11(5):379–385. doi:10.5152/akd.2011.104

    PubMed  Google Scholar 

  17. Gozal D, Lipton AJ, Jones KL (2002) Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep 25(1):59–65

    PubMed  Google Scholar 

  18. Schulz R, Hummel C, Heinemann S, Seeger W, Grimminger F (2002) Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med 165(1):67–70

    Article  PubMed  Google Scholar 

  19. Berger S, Aronson D, Lavie P, Lavie L (2013) Endothelial progenitor cells in acute myocardial infarction and sleep-disordered breathing. Am J Respir Crit Care Med 187(1):90–98

    Article  CAS  PubMed  Google Scholar 

  20. Valipour A, Litschauer B, Mittermayer F, Rauscher H, Burghuber OC, Wolzt M (2004) Circulating plasma levels of vascular endothelial growth factor in patients with sleep disordered breathing. Respir Med 98(12):1180–1186

    Article  PubMed  Google Scholar 

  21. Petrisor BA, Keating J, Schemitsch E (2006) Grading the evidence: levels of evidence and grades of recommendation. Injury 37(4):321–327. doi:10.1016/j.injury.2006.02.001

    Article  CAS  PubMed  Google Scholar 

  22. Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13. doi:10.1186/1471-2288-5-13

    Article  PubMed  PubMed Central  Google Scholar 

  23. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558. doi:10.1002/sim.1186

    Article  PubMed  Google Scholar 

  24. Maeder MT, Strobel W, Christ M, Todd J, Estis J, Wildi K, Thalmann G, Hilti J, Brutsche M, Twerenbold R, Rickli H, Mueller C (2015) Comprehensive biomarker profiling in patients with obstructive sleep apnea. Clin Biochem 48(4–5):340–346. doi:10.1016/j.clinbiochem.2014.09.005

    Article  CAS  PubMed  Google Scholar 

  25. Salord N, Gasa M, Mayos M, Fortuna-Gutierrez AM, Montserrat JM, Sánchez-de-la-Torre M, Barceló A, Barbé F, Vilarrasa N, Monasterio C (2014) Impact of OSA on biological markers in morbid obesity and metabolic syndrome. J Clin Sleep Med 10(3):263–270

    PubMed  PubMed Central  Google Scholar 

  26. Briancon-Marjollet A, Henri M, Pepin JL, Lemarie E, Levy P, Tamisier R (2014) Altered in vitro endothelial repair and monocyte migration in obstructive sleep apnea: implication of VEGF and CRP. Sleep 37(11):1825–1834

    PubMed  PubMed Central  Google Scholar 

  27. Hirata Y, Nabekura T, Maruyama H, Aonuma K, Satoh M (2013) Elevation of plasma basic fibroblast growth factor after nocturnal hypoxic events in patients with obstructive sleep apnea syndrome. Springerplus 2(1):260. doi:10.1186/2193-1801-2-260

    Article  PubMed  PubMed Central  Google Scholar 

  28. Ciftci TU, Kokturk O, Demirtas S, Gulbahar Ö, Bukan N (2011) Consequences of hypoxia-reoxygenation phenomena in patients with obstructive sleep apnea syndrome. Ann Saudi Med 31(1):14–18

    Article  PubMed  PubMed Central  Google Scholar 

  29. de la Pena M, Barcelo A, Barbe F, Pierola J, Pons J, Rimbau E, Ayllon O, Agusti AGN (2008) Endothelial function and circulating endothelial progenitor cells in patients with sleep apnea syndrome. Respiration 76(1):28–32

    Article  PubMed  Google Scholar 

  30. Hayashi M, Fujimoto K, Urushibata K, Takamizawa A, Kinoshita O, Kubo K (2006) Hypoxia-sensitive molecules may modulate the development of atherosclerosis in sleep apnoea syndrome. Respirology 11(1):24–31

    Article  PubMed  Google Scholar 

  31. Teramoto S, Kume H, Yamamoto H, Ishii T, Miyashita A, Matsuse T, Akishita M, Toba K, Ouchi Y (2003) Effects of oxygen administration on the circulating vascular endothelial growth factor (VEGF) levels in patients with obstructive sleep apnea syndrome. Intern Med 42(8):681–685

    Article  CAS  PubMed  Google Scholar 

  32. Lavie L, Kraiczi H, Hefetz A, Ghandour H, Perelman A, Hedner J, Lavie P (2002) Plasma Vascular Endothelial Growth Factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med 165(12):1624–1628

    Article  PubMed  Google Scholar 

  33. Ma J, Xu Y, Zhang Z, Liu H, Xiong W, Xu S (2007) Serum level of vascular endothelial growth factor in patients with obstructive sleep apnea hypopnea syndrome. J Huazhong Univ Sci Technol 27(2):157–160

    Article  CAS  Google Scholar 

  34. Kukwa W, Glowczynska R, Filipiak KJ, Kukwa A, Opolski G, Budaj-Fidecka A, Grabowski M, Galazka A, Krzeski A, Kuzminska M, Czarnecka AM (2013) Serum EPO and VEGF levels in patients with sleep-disordered breathing and acute myocardial infarction. Sleep Breath 17(3):1063–1069

    Article  PubMed  PubMed Central  Google Scholar 

  35. Imagawa S, Yamaguchi Y, Higuchi M, Neichi T, Hasegawa Y, Mukai HY, Suzuki N, Yamamoto M, Nagasawa T (2001) Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea-hypopnea syndrome. Blood 98(4):1255–1257

    Article  CAS  PubMed  Google Scholar 

  36. Peled N, Shitrit D, Bendayan D, Peled E, Kramer MR (2007) Association of elevated levels of vascular endothelial growth factor in obstructive sleep apnea syndrome with patient age rather than with obstructive sleep apnea syndrome severity. Respiration 74(1):50–55

    Article  CAS  PubMed  Google Scholar 

  37. Kaditis AG, Alexopoulos EI, Karadonta I, Kostadima E, Kiropoulos T, Gourgoulianis K, Syrogiannopoulos GA (2006) Obstructive sleep-disordered breathing and plasma levels of vascular endothelial growth factor in children. Respir Med 100(5):835–840. doi:10.1016/j.rmed.2005.09.003

    Article  PubMed  Google Scholar 

  38. Webb NJ, Bottomley MJ, Watson CJ, Brenchley PE (1998) Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin Sci (Lond) 94(4):395–404

    Article  CAS  Google Scholar 

  39. Jelkmann W (2001) Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem 47(4):617–623

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Xiao-Bin Zhang or Hui-Qing Zeng.

Ethics declarations

Funding

This work was supported by grant 2013-2-88 for Youth Research Fund from Fujian Provincial Health Bureau and grant 3502Z20154019 for Fund from Xiamen Science and Technology Bureau.

Conflict of interest

All authors declared that they had no conflict of interest.

Ethical approval

This study was a meta-analysis, and did not concern with human participants performed by any of the authors.

Additional information

All authors contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, XB., Jiang, XT., Cai, FR. et al. Vascular endothelial growth factor levels in patients with obstructive sleep apnea: a meta-analysis. Eur Arch Otorhinolaryngol 274, 661–670 (2017). https://doi.org/10.1007/s00405-016-4102-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-016-4102-6

Keywords

Navigation